Skip to main content
. 2018 Jun 21;10(6):1424–1441. doi: 10.18632/aging.101478

Figure 2.

Figure 2

Overall forest plots of objective response rate (ORR), progression-free survival (PFS) and overall survival (OS) for bevacizumab-induced hypertension in patients with metastatic colorectal cancer.